Bukwang Pharm Long-term Investment Intensity

Latest as of December 2019: 13.6%

Bukwang Pharm long-term investment intensity. Bukwang Pharm (003000) has a Long-term Investment Intensity of 13.6% as of December 2019. Long-term investments of ₩53.00 Billion represent 13.6% of total assets of ₩388.53 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Bukwang Pharm (003000) financial obligations for a breakdown of total debt and financial obligations.

LT Investment Intensity

13.6%
LT Investments / Total Assets

Long-term Investments

₩53.00 Billion
KRW

Total Assets

₩388.53 Billion
KRW

Country

Korea
KO

Long-term Investment Intensity of Bukwang Pharm (2013–2019)

Long-term investment intensity of Bukwang Pharm from 2013 to 2019. This chart shows how Bukwang Pharm's Long-term Investment Intensity has evolved across 7 annual periods from 2013 to 2019. As of December 2019, the intensity stands at 13.6%, reflecting long-term investments of ₩53.00 Billion against total assets of ₩388.53 Billion KRW.

Bukwang Pharm Long-term Investment Intensity by Year (2013–2019)

Bukwang Pharm long-term investment intensity by year from 2013 to 2019. The table below presents the year-by-year Long-term Investment Intensity for Bukwang Pharm from 2013 to 2019, covering 7 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 003000 asset base.

Year LT Investment Intensity LT Investments (KRW) Total Assets Change (pp)
2019 13.6% ₩53.00 Billion ₩388.53 Billion ▼ -9.5 pp
2018 23.2% ₩114.33 Billion ₩493.62 Billion ▲ +7.9 pp
2017 15.2% ₩36.02 Billion ₩236.23 Billion ▲ +3.2 pp
2016 12.1% ₩28.64 Billion ₩237.63 Billion ▲ +1.4 pp
2015 10.6% ₩27.00 Billion ₩253.66 Billion ▲ +6.6 pp
2014 4.1% ₩9.63 Billion ₩236.82 Billion ▲ +0.3 pp
2013 3.8% ₩8.62 Billion ₩228.21 Billion —
pp = percentage points